Compare FIVN & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVN | NEOG |
|---|---|---|
| Founded | 2001 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | 1989 |
| Metric | FIVN | NEOG |
|---|---|---|
| Price | $19.39 | $9.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $32.13 | $8.83 |
| AVG Volume (30 Days) | 1.6M | ★ 4.5M |
| Earning Date | 02-19-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $1,127,466,000.00 | $880,319,000.00 |
| Revenue This Year | $12.29 | N/A |
| Revenue Next Year | $9.40 | $1.80 |
| P/E Ratio | $54.43 | ★ N/A |
| Revenue Growth | ★ 12.48 | N/A |
| 52 Week Low | $17.71 | $3.87 |
| 52 Week High | $49.90 | $13.15 |
| Indicator | FIVN | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 75.35 |
| Support Level | $18.41 | $6.89 |
| Resistance Level | $20.11 | $7.51 |
| Average True Range (ATR) | 0.67 | 0.41 |
| MACD | -0.01 | 0.20 |
| Stochastic Oscillator | 44.95 | 67.45 |
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.